Advanced Search

 

Study ID Status Title Patient Level Data
W5350856 Completed Survey on the pharmacy follow up of Alli purchasers
W7781293 Completed An Exploratory Study to Measure the Effect of Two Dietary Fibers on Satiety and Glycemic Parameters
W91-016 Completed The Pharmacokinetics and Tolerability of Ondansetron 4mg Given as an Intramuscular Injection
WELL 029 Completed Multicenter Evaluation of the Efficacy and Safety of Low Doses of Wellbatrin vs. Placebo in Depressed Inpatients
Well 08 Completed Phase II Placebo-Controlled Evaluation of Efficacy: Multiclinic Study
WELL 203 Completed A Multicenter Evaluation of the Safety and Efficacy of 150mg/day and 300mg/day of Bupropion HCl Sustained-Release Versus Placebo in Depressed Outpatients
WELL 205 Completed A multicenter dose-response evaluation of the safety and efficacy of bupropion HCI sustained-release versus placebo in depressed outpatients
WELL 208 Completed Safety Surveillance Study for WELLBUTRIN® (bupropion hydrochloride) Sustained Release
Well 209 Completed The Safety and Efficacy of Wellbutrin Sustained Release and Sertraline in Depressed Outpatients
WELL 212 Completed A multicenter evaluation of the safety and efficacy of two flexible doses of WELLBUTRIN sustained-release versus placebo in depressed outpatients
Well 41 Completed A Single-Blind Pilot Study of the Safety and Efficacy of Wellbutrin in Children with Attention Deficit and/or Conduct Disorders
Well 84A Completed Multicenter evaluation of the efficacy and safety of a 300 mg daily dose of Wellbutrin versus placebo in depressed outpatients
Well 86A Completed Prospective open evaluation of the seizure incidence with bupropion hydrochloride (Wellbutrin®)
Wellbutrin 06 Completed Phase II Placebo-Controlled Proof of Efficacy, Multi-clinic Study
Wellbutrin 25 Completed Multicenter Evaluation of the Efficacy and Safety of Bupropion vs. Placebo in Depressed Inpatients
WHP:86:34 Completed A preliminary study to investigate the safety, tolerability and pharmacokinetics of intranasally administered GR43175N in 6 healthy male volunteers.
WHP:86:38 Completed GR43175 base plasma levels after single oral doses (dispersible tablets) of 70mg, 140mg and 280mg GR43175 base (as succinate) in 6 healthy volunteers.
WHP:87:12, WHP:88:12 Completed Radioisotope Study To Investigate The Metabolic Disposition Of GR38032 In Man
WHP:88:03 Completed To Investigate the Effect of Regular Treatment With Salmeterol on the Cardiovascular, Tremorogenic, Metabolic, and Respiratory Effects of Inhaled Salbutamol (Study No. WHP:88:03)
WHP:88:13 Completed Metabolic Studies on Salmeterol Hydroxynaphthoate. The Absorption, Metabolism and Excretion of 14C-Salmeterol in Man After Oral Administration of 14C-Salmeterol Hydroxynaphthoate (1mg Base)
WHP:88:15 Completed The Effect of Regular Treatment with Salmeterol on the Cardiovascular System, 12-Lead ECG, Skeletal Muscle Tremor and Lung Function
WHP:88:16 Completed The effect of two consecutive doses of GR43175N, administered as an intranasal spray, on peak plasma drug levels
WHP:88:20 Completed To determine the effect of food on the pharmacokinetics of oral GR43175C
WHP:88:34 Completed To examine the pharmacokinetics, safety and tolerability of repeat oral dosing with GR43175C.
WHP:88:35 Completed The safety, tolerability and pharmacokinetics of two oral doses of GR43175C separated by two hours.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.